bcx 1812 has been researched along with lopinavir in 1 studies
Studies (bcx 1812) | Trials (bcx 1812) | Recent Studies (post-2010) (bcx 1812) | Studies (lopinavir) | Trials (lopinavir) | Recent Studies (post-2010) (lopinavir) |
---|---|---|---|---|---|
25 | 1 | 12 | 2,383 | 499 | 1,358 |
Protein | Taxonomy | bcx 1812 (IC50) | lopinavir (IC50) |
---|---|---|---|
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.7 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 9.12 | |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | 0.035 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 8.5114 | |
Protease | Human immunodeficiency virus 1 | 0.025 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 7.6 | |
Protease | Human immunodeficiency virus 1 | 0.0175 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E | 1 |
1 other study(ies) available for bcx 1812 and lopinavir
Article | Year |
---|---|
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship | 2009 |